- Q1 2024 IQVIA Holdings Inc Earnings Call TranscriptMay 02, 2024€206.5 (-4.66%)Earnings
- IQVIA Holdings Inc at Citigroup Inc Unplugged Medtech and Life Sciences Access Day TranscriptFeb 29, 2024
- Q4 2023 IQVIA Holdings Inc Earnings Call TranscriptFeb 14, 2024€226 (+13.00%)Earnings
- IQVIA Holdings Inc at Evercore ISI HealthCONx Conference TranscriptNov 29, 2023
- Q3 2023 IQVIA Holdings Inc Earnings Call TranscriptNov 01, 2023€168.8 (+2.18%)Earnings
- IQVIA Holdings Inc at Robert W Baird Global Healthcare Conference TranscriptSep 13, 2023
- IQVIA Holdings Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Q2 2023 IQVIA Holdings Inc Earnings Call TranscriptAug 01, 2023€199 (-1.73%)Earnings
- IQVIA Holdings Inc. - Special Call TranscriptMay 24, 2023
- Q1 2023 IQVIA Holdings Inc Earnings Call TranscriptApr 27, 2023€164.6 (-3.18%)Earnings
- IQVIA Holdings Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2023
- Q4 2022 IQVIA Holdings Inc Earnings Call TranscriptFeb 10, 2023€208.4 (-2.71%)Earnings
- IQVIA Holdings Inc Corporate Call TranscriptJan 18, 2023
- IQVIA Holdings Inc at Credit Suisse Healthcare Conference TranscriptNov 08, 2022
- Q3 2022 IQVIA Holdings Inc Earnings Call TranscriptOct 26, 2022€200.1 (+1.47%)Earnings
- IQVIA Holdings Inc at Robert W Baird Global Healthcare Conference TranscriptSep 14, 2022
- IQVIA Holdings Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2022
- Q2 2022 IQVIA Holdings Inc Earnings Call TranscriptJul 21, 2022€220.7 (+1.92%)Earnings
- IQVIA Holdings Inc at Jefferies Healthcare Conference TranscriptJun 10, 2022
- IQVIA Holdings Inc. - Special Call TranscriptMay 04, 2022
- Q1 2022 IQVIA Holdings Inc Earnings Call TranscriptApr 27, 2022€198.92 (+2.72%)Earnings
- IQVIA Holdings Inc at Barclays Global Healthcare Conference TranscriptMar 16, 2022
- IQVIA Holdings Inc at Citi Healthcare Conference (Virtual) TranscriptFeb 24, 2022
- Q4 2021 IQVIA Holdings Inc Earnings Call TranscriptFeb 15, 2022€200.4 (-5.20%)Earnings
- IQVIA Holdings Inc Analyst and Investor Conference (Virtual) TranscriptNov 16, 2021
- Q3 2021 IQVIA Holdings Inc Earnings Call TranscriptOct 21, 2021€217.4 (+0.69%)Earnings
- IQVIA Holdings Inc at Robert W Baird Global Healthcare Conference (Virtual) TranscriptSep 14, 2021
- Q2 2021 IQVIA Holdings Inc Earnings Call TranscriptJul 27, 2021€203 (-2.54%)Earnings
- IQVIA Holdings Inc at William Blair Growth Stock Conference (Virtual) TranscriptJun 02, 2021
- Q1 2021 IQVIA Holdings Inc Earnings Call TranscriptApr 22, 2021€185.95 (+1.95%)Earnings
- IQVIA Holdings Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 09, 2021
- Q4 2020 IQVIA Holdings Inc Earnings Call TranscriptFeb 10, 2021€156 (+1.96%)Earnings
- Q3 2020 IQVIA Holdings Inc Earnings Call TranscriptOct 20, 2020€146 (+5.04%)Earnings
- Q2 2020 IQVIA Holdings Inc Earnings Call TranscriptJul 22, 2020€140 (+2.19%)Earnings
- Q1 2020 IQVIA Holdings Inc Earnings Call TranscriptApr 28, 2020€125 (+4.17%)Earnings
- Q4 2019 IQVIA Holdings Inc Earnings Call TranscriptFeb 12, 2020€152 (+2.70%)Earnings
- Q3 2019 IQVIA Holdings Inc Earnings Call TranscriptOct 30, 2019€129 (-4.44%)Earnings
- IQVIA Holdings Inc at Robert W Baird Global Healthcare Conference TranscriptSep 04, 2019
- Q2 2019 IQVIA Holdings Inc Earnings Call TranscriptJul 24, 2019€142.94 (+1.94%)Earnings
- IQVIA Holdings Inc Analyst and Investor Conference TranscriptJun 18, 2019
- IQVIA Holdings Inc at William Blair Growth Stock Conference TranscriptJun 05, 2019
- Q1 2019 IQVIA Holdings Inc Earnings Call TranscriptMay 01, 2019€123.58Earnings
- IQVIA Holdings Inc at Alliance for Regenerative Medicine Cell & Gene Meeting on the Mediterranean TranscriptApr 23, 2019
- IQVIA Holdings Inc at Barclays Global Healthcare Conference TranscriptMar 12, 2019
- Q4 2018 IQVIA Holdings Inc Earnings Call TranscriptFeb 14, 2019€124.71 (+8.04%)Earnings
IQVIA Holdings Inc at Citigroup Inc Unplugged Medtech and Life Sciences Access Day Transcript
(technical difficulty)
thinking about both the R&DS piece and the TAS piece and then we can kind of dive in from there.
Questions & Answers
Sure. Well, you know that the TAS business went through a period of softening revenue last year. And Q4, I think, was our softest quarter of all. What we're looking for in the TAS business as we go into 2024 -- through 2024, it's kind of almost a mirror image in terms of growth from what we saw in 2023, which is to say 2023 started out strong and the growth rate trailed off as we saw pharma clients cut back on discretionary spending.
We see demand coming back, but gradually towards the back half of the year. So you had the downward trend last year in growth, and we expect the revenue to bounce back growth as we go through the year. And you might ask what gives us confidence in that and really -- and we get that question frequently, it's hard to call
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)